9. March 2022 - Press Releases
With capital, sector expertise, experience and a strong network, the healthcare investor SHS supports companies on their growth path.
![](https://www.shs-capital.eu/wp-content/uploads/2022/02/21_09_21_SHS_Capital_BLAZEJEWSKI_Investitionsfilm_Stills.00_00_38_22.Standbild000-scaled-1-1024x576.jpg)
Since 1993, the Tübingen-based SHS Gesellschaft für Beteiligungsmanagement mbH has successfully developed and sold more than 68 companies from the medtech industry with capital and know-how. Read three success stories from our contribution to the Voelker brochure “Potentials MedTech 2022”, in which big names in medical technology have their say.